A team from New Delhi-based P&A Law Offices represented Daiichi Sankyo when both the Delhi High Court and Supreme Court recently gave the go-ahead for the enforcement of a ₹35 billion (US$536 million) arbitral award against the founders of Ranbaxy, brothers Malvinder Singh and Shivinder Singh.
“This case involves the highest damages ever awarded against Indian nationals,” managing partner Anand Pathak told Asia Business Law Journal. “It is not merely a case of litigation and enforcement of an arbitral award … it has become a case study in Japan and other jurisdictions of the challenges of doing transactions in India. The case was decided in Daiichi’s favour quickly and effectively by Indian Courts, showing the strength of the Indian judicial system.”
On 31 January, the Delhi High Court passed an order allowing the enforcement of a 29 April 2016 arbitration award against the Singh brothers. On 16 February, the Supreme Court dismissed an appeal against the high court order. The Singh brothers were represented by DMD Advocates senior partner Anuradha Dutt.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
